WHO sends experts to help Congo diagnose mystery disease

WHO sends experts to help Congo diagnose mystery disease


The town of Kavumu where there has been an outbreak of mpox in Kabare territory, South Kivu region, Democratic Republic of Congo, on Tuesday, Sept. 3, 2024.

Bloomberg | Bloomberg | Getty Images

The World Health Organization said on Friday it is deploying experts to support health authorities in the Democratic Republic of the Congo to investigate an as-yet undiagnosed disease in a remote area of the country.

The WHO experts are on their way to Panzi, a locality in the southwestern Kwango province, where they will deliver essential medicines and diagnostic kits to help analyse the cause of the illness, which local authorities said killed 143 people in November.

Laboratory tests are being conducted to determine the cause, the WHO said, adding that it would share more information as soon as it was available.



Source

U.S. added just 73,000 jobs in July and numbers for prior months were revised much lower
World

U.S. added just 73,000 jobs in July and numbers for prior months were revised much lower

An attendee holds an “Entry Level Jobs” flyer at a City Career Fair hiring event in Sacramento, California, on Feb. 27, 2025. David Paul Morris | Bloomberg | Getty Images Nonfarm payroll growth was slower than expected in July and the unemployment rate ticked higher, raising potential trouble signs for the U.S. labor market. Job […]

Read More
Trump’s drug price ultimatum sets pharma firms scrambling
World

Trump’s drug price ultimatum sets pharma firms scrambling

Key Points A fresh ultimatum demanding “binding commitments” to lower U.S. drug prices sent pharma firms scrambling Friday. President Trump sent letters to 17 major firms outlining the steps they must take to cut costs. Healthcare stocks tumbled Friday, following broader market losses as investors digested Trump’s amended tariffs. Pharmaceutical firms are scrambling to respond […]

Read More
Chevron profit hit by low crude oil prices and loss from Hess acquisition
World

Chevron profit hit by low crude oil prices and loss from Hess acquisition

Chevron on Friday reported second-quarter earnings that took a substantial hit due to low oil prices and a loss on its acquisition of Hess Corporation. The oil major’s net income declined about 44% to $2.49 billion, or $1.45 per share, from $4.43 billion, or $2.43 per share, in the same period last year. Chevron booked […]

Read More